AbCellera Biologics (8QQ) Revenue

7 Followers

AbCellera Biologics Revenue

AbCellera Biologics had a revenue of 4.05M in the quarter ending Jun 30, 2026, with -51.29%. This bring the company's revenue in the last twelve months to 66.17M, Increased -16.46%. In the fiscal year ending Dec 31, 2025, AbCellera Biologics had annual revenue of 75.13M with 160.56% growth.

Revenue (ttm)

66.17M

Revenue Growth

90.86%

P/S Ratio

40.48

Revenue/Employee

€133,680

Employees

562

Market Cap

€3.04B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	75.13M	46.30M	+160.56%
Dec 31, 2024	28.83M	-9.19M	-24.17%
Dec 31, 2023	38.02M	-447.40M	-92.17%
Dec 31, 2022	485.42M	110.22M	+29.38%
Dec 31, 2021	375.20M	142.05M	+60.92%
Dec 31, 2020	233.16M	221.54M	+1,907.88%
Dec 31, 2019	11.61M	2.78M	+31.49%
Dec 31, 2018	8.83M	―	―